- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of PD-1/PD-L1 Pathway in Cancer by Noncoding RNAs
Authors
Keywords
-
Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-21
DOI
10.1007/s12253-019-00735-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
- (2019) Lanlan Gao et al. EBioMedicine
- Upregulation of long noncoding RNA SNHG20 promotes cell growth and metastasis in esophageal squamous cell carcinoma via modulating ATM-JAK-PD-L1 pathway
- (2019) Chunrong Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling
- (2018) Xianglu Ji et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Overexpressed miR-195 attenuated immune escape of diffuse large B-cell lymphoma by targeting PD-L1
- (2018) Bai He et al. BIOMEDICINE & PHARMACOTHERAPY
- Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer
- (2018) Dan Tan et al. Cancer Biomarkers
- MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLC
- (2018) Wei-Bin Xie et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint
- (2018) Zhen Tao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448/IDO
- (2018) Xinhong Pei et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- The miR-3127-5p/p-STAT3 axis up-regulates PD-L1 inducing chemoresistance in non-small-cell lung cancer
- (2018) Dongfang Tang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy
- (2018) Jiajia Xi et al. ONCOGENE
- miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer
- (2018) Zhao-jia Gao et al. PATHOLOGY RESEARCH AND PRACTICE
- MiR-21 improves invasion and migration of drug-resistant lung adenocarcinoma cancer cell and transformation of EMT through targeting HBP1
- (2018) Chongyu Su et al. Cancer Medicine
- MicroRNA-92a promotes tumor growth and suppresses immune function through activation of MAPK/ERK signaling pathway by inhibiting PTEN in mice bearing U14 cervical cancer
- (2018) Zeng-Hui Li et al. Cancer Medicine
- Silencing of Long Non-coding RNA MIAT Sensitizes Lung Cancer Cells to Gefitinib by Epigenetically Regulating miR-34a
- (2018) Yunfeng Fu et al. Frontiers in Pharmacology
- Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer
- (2018) G V Long et al. ANNALS OF ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma
- (2018) Bojan Zaric et al. Clinical Lung Cancer
- Follicular helper T cells promote the effector functions of CD8+ T cells via the provision of IL-21, which is downregulated due to PD-1/PD-L1-mediated suppression in colorectal cancer
- (2018) Weiwei Shi et al. EXPERIMENTAL CELL RESEARCH
- EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions
- (2018) Sho Sasaki et al. Gastric Cancer
- Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer
- (2018) Mondira Ray et al. GENES CHROMOSOMES & CANCER
- Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
- (2018) Sabine E. Grimm et al. PHARMACOECONOMICS
- Engineering Exosomes for Cancer Therapy
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-155 induction via TNF-α and IFN-γ suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells
- (2017) Daniel Yee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two microRNA signatures for malignancy and immune infiltration predict overall survival in advanced epithelial ovarian cancer
- (2017) Ilya Korsunsky et al. JOURNAL OF INVESTIGATIVE MEDICINE
- MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs
- (2017) A R Pyzer et al. LEUKEMIA
- Variant SNPs at the microRNA complementary site in the B7-H1 3′-untranslated region increase the risk of non-small cell lung cancer
- (2017) Wenwen Du et al. Molecular Medicine Reports
- Helicobacter Pylori Promote B7-H1 Expression by Suppressing miR-152 and miR-200b in Gastric Cancer Cells
- (2017) Gengchen Xie et al. PLoS One
- MicroRNA-146a induces immune suppression and drug-resistant colorectal cancer cells
- (2017) Samaneh Khorrami et al. TUMOR BIOLOGY
- miR-21 targets and inhibits tumor suppressor gene PTEN to promote prostate cancer cell proliferation and invasion: An experimental study
- (2017) Yu Yang et al. Asian Pacific Journal of Tropical Medicine
- MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer
- (2017) Chen Liang et al. Cell Death & Disease
- miR-21 inhibition of LATS1 promotes proliferation and metastasis of renal cancer cells and tumor stem cell phenotype
- (2017) Feng An et al. Oncology Letters
- miR-21 modulates the effect of EZH2 on the biological behavior of human lung cancer stem cells in vitro
- (2017) Hui Xia et al. Oncotarget
- The miR-25-93-106b cluster regulates tumor metastasis and immune evasion via modulation of CXCL12 and PD-L1
- (2017) Michele Cioffi et al. Oncotarget
- PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p
- (2017) Valentina Audrito et al. Oncotarget
- PD-1/PD-L1 Pathway in Breast Cancer
- (2017) Florian Schütz et al. Oncology Research and Treatment
- Non–Small Cell Lung Cancer
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- PD-1/PD-L and autoimmunity: A growing relationship
- (2016) Mohammad Reza Zamani et al. CELLULAR IMMUNOLOGY
- miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential
- (2016) Michal Wozniak et al. CURRENT MEDICINAL CHEMISTRY
- Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
- (2016) Keisuke Kataoka et al. NATURE
- The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines
- (2016) M. Fragni et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy
- (2016) Dickran Kazandjian et al. ONCOLOGIST
- miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint
- (2016) Shaohua Xu et al. Nature Communications
- MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN
- (2016) Xinying Xue et al. Oncotarget
- The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer
- (2016) Lian Zhao et al. Oncotarget
- Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer
- (2016) Yang Shao et al. Oncotarget
- Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
- (2016) Kyle C. Strickland et al. Oncotarget
- Pembrolizumab (Keytruda)
- (2016) Gerry Kwok et al. Human Vaccines & Immunotherapeutics
- CXCR4–CXCL12–CXCR7, TLR2–TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients
- (2016) Crescenzo D'Alterio et al. OncoImmunology
- Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer
- (2015) Mette Winther et al. ACTA ONCOLOGICA
- AML evolution from preleukemia to leukemia and relapse
- (2015) Liran I. Shlush et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Principles of miRNA–mRNA interactions: beyond sequence complementarity
- (2015) Fabian Afonso-Grunz et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
- (2015) Xi Wang et al. CELLULAR SIGNALLING
- Association of miR-21 with esophageal cancer prognosis: a meta-analysis
- (2015) S.-W. Wen et al. GENETICS AND MOLECULAR RESEARCH
- The Relevance of miRNA-21 in HSV-Induced Inflammation in a Mouse Model
- (2015) Bunsoon Choi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-146a inhibits epithelial mesenchymal transition in non-small cell lung cancer by targeting insulin receptor substrate 2
- (2015) DONG HO PARK et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The Oncogenic MicroRNA-21 Inhibits the Tumor Suppressive Activity of FBXO11 to Promote Tumorigenesis
- (2015) Chuan He Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
- (2015) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- miR-21 and miR-145 cooperation in regulation of colon cancer stem cells
- (2015) Yingjie Yu et al. Molecular Cancer
- MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer
- (2015) Anna Rusek et al. Molecular Cancer
- The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer
- (2015) Yu Fujita et al. MOLECULAR THERAPY
- MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
- (2015) Jun Wei et al. NEURO-ONCOLOGY
- Immunogenicity of somatic mutations in human gastrointestinal cancers
- (2015) E. Tran et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Overview of MicroRNA Biology
- (2015) Ashley Mohr et al. SEMINARS IN LIVER DISEASE
- PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival
- (2015) Z -Z Yang et al. Blood Cancer Journal
- Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
- (2015) Elisabetta Vergani et al. Oncotarget
- microRNA-4717 differentially interacts with its polymorphic target in the PD1 3’ untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases
- (2015) Guoyu Zhang et al. Oncotarget
- The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy
- (2015) Brock Humphries et al. Oncotarget
- Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression
- (2015) Qiuyan Guo et al. Scientific Reports
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial
- (2014) F. Barlesi et al. ANNALS OF ONCOLOGY
- The expression of miR-21 and miR-375 predict prognosis of esophageal cancer
- (2014) Chengrui Fu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression
- (2014) Chunxiao Xu et al. CANCER CELL
- Nasopharyngeal cancer-derived microRNA-21 promotes immune suppressive B cells
- (2014) Bei-Ping Miao et al. Cellular & Molecular Immunology
- MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer
- (2014) Jianjie Zhu et al. HUMAN IMMUNOLOGY
- PD-1 deletion restores susceptibility to experimental autoimmune encephalomyelitis in miR-155-deficient mice
- (2014) J. Zhang et al. INTERNATIONAL IMMUNOLOGY
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-513 Regulates B7-H1 Translation and Is Involved in IFN- -Induced B7-H1 Expression in Cholangiocytes
- (2014) A.-Y. Gong et al. JOURNAL OF IMMUNOLOGY
- Role of miR-200 family members in survival of colorectal cancer patients treated with fluoropyrimidines
- (2014) Tania Diaz et al. JOURNAL OF SURGICAL ONCOLOGY
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44hi Stem-Like NSCLC Cells
- (2014) Yang Shi et al. PLoS One
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- MicroRNAs in Immune Response and Macrophage Polarization
- (2013) Gang Liu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- miR-21, miR-221 and miR-222 expression and prostate cancer recurrence among obese and non-obese cases
- (2013) Ernest K Amankwah et al. ASIAN JOURNAL OF ANDROLOGY
- Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro
- (2013) Jun Deng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Location, Location, Location: Macrophage Positioning within Tumors Determines Pro- or Antitumor Activity
- (2013) Lee B. Rivera et al. CANCER CELL
- Blockade of PD-1/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice
- (2013) Yan Ge et al. CANCER LETTERS
- MiR-200, a new star miRNA in human cancer
- (2013) Xiangling Feng et al. CANCER LETTERS
- Long Noncoding RNAs: Cellular Address Codes in Development and Disease
- (2013) Pedro J. Batista et al. CELL
- Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance
- (2013) A. Jahangiri et al. CLINICAL CANCER RESEARCH
- Functional Role of miR-34 Family in Human Cancer
- (2013) Rui Wang et al. CURRENT DRUG TARGETS
- Long non-coding RNAs: modulators of nuclear structure and function
- (2013) Jan H Bergmann et al. CURRENT OPINION IN CELL BIOLOGY
- Tumor-suppressive Function of Protein-tyrosine Phosphatase Non-receptor Type 23 in Testicular Germ Cell Tumors Is Lost upon Overexpression of miR142–3p microRNA
- (2013) Kiyoko Tanaka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer
- (2013) J Wang et al. ONCOGENE
- miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis
- (2013) DE-TAO WANG et al. ONCOLOGY REPORTS
- miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells
- (2013) Gang Chen et al. PLoS One
- miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN
- (2013) Shou-mei Yang et al. TOXICOLOGY
- PD-1 Inhibitors Raise Survival in NSCLC
- (2013) Cancer Discovery
- miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer
- (2012) J Zhang et al. BRITISH JOURNAL OF CANCER
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer
- (2012) Riad Naim Younes et al. Revista da Associacao Medica Brasileira
- miR-21 Downregulated TCF21 to Inhibit KISS1 in Renal Cancer
- (2012) Hui Zhang et al. UROLOGY
- miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer
- (2012) Yuejuan Xu et al. Gastroenterology Research and Practice
- miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer
- (2012) Sabrina Thalita Reis et al. BMC Urology
- The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21
- (2011) Dimitrios Iliopoulos et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses
- (2011) M. N. Cabili et al. GENES & DEVELOPMENT
- A frequent somatic mutation in CD274 3′-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding
- (2011) Weipeng Wang et al. HUMAN MUTATION
- PD-L2 is predominantly expressed by Th2 cells
- (2011) W. Joost Lesterhuis et al. MOLECULAR IMMUNOLOGY
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
- (2010) Maite Huarte et al. CELL
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma
- (2009) R. Karim et al. CLINICAL CANCER RESEARCH
- MicroRNAs and Lung Cancer: New Oncogenes and Tumor Suppressors, New Prognostic Factors and Potential Therapeutic Targets
- (2009) Cecile Ortholan et al. CURRENT MEDICINAL CHEMISTRY
- Cryptosporidium parvumInduces B7‐H1 Expression in Cholangiocytes by Down‐Regulating MicroRNA‐513
- (2009) Ai‐Yu Gong et al. JOURNAL OF INFECTIOUS DISEASES
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- MicroRNA Signature Predicts Survival and Relapse in Lung Cancer
- (2008) Sung-Liang Yu et al. CANCER CELL
- Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation
- (2008) M. E. Dinger et al. GENOME RESEARCH
- Immune-mediated dormancy: an equilibrium with cancer
- (2008) Michele W. L. Teng et al. JOURNAL OF LEUKOCYTE BIOLOGY
- miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
- (2008) Zhiyu Zhang et al. LABORATORY INVESTIGATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started